A Service For Professionals Wednesday, September 20, 2017
Contact (202) 540-8337

World News Report

A Service For Professionals Wednesday, September 20, 2017 11583 Sources 405,020,345 Articles 3,235,762 Readers
Contact (202) 540-8337

Breaking News

< >

OGB Consulting Discuss Animal Models at Pain Therapeutics 2014

Pain Therapeutics 2014

Pain Therapeutics 2014

It's an excellent forum for networking and discussion”
— OGB Consulting

LONDON, LONDON, UNITED KINGDOM, April 24, 2014 /EINPresswire.com/ -- SMi Group would like to thank Professor Odd-Geir Berge, Independent Consultant from OGB Consulting, for taking the time to give us his views on this year’s Pain Therapeutics conference, challenges facing the industry and the future of Pain Therapeutics.

Professor Berge will be making a keynote address at the 14th annual conference taking place on 19th and 20th May in Central London. His presentation entitled: The Translation Gap and Assessing Failures, Case Study1 – Pre-Clinical Perspective, will discuss translation from animal models to man, failed pain mechanisms and experimental models versus clinical trials.

The brochure is currently available at www.pain-therapeutics.co.uk

Snippet of Interview:

Q. About you – what is your role and current activities?
I am working as a consultant with issues related to project generation and development in the neuroscience area, particularly within pain control. Academically, I am engaged in research at Uppsala University Multidisciplinary Pain Center.

Q. What is the value/strengths of this year’s Pain Therapeutics event?
It's an excellent forum for networking and discussion

Q. What will attendees take away from your talk?
An understanding of how animal models can contribute to project generation and propagation - and how to avoid some of the traps in the translational process.

Q. What is the future for Pain Therapeutics?
There is undoubtedly a great medical need for more efficacious and better tolerated treatments. Incremental improvement of existing therapies, e.g. in formulation and personalized administration is likely to play a role. In a longer perspective, we may hope that tackling the challenges of anti-NGF and ion channel approaches will change the way pain is treated pharmacologically.

The full interview can be read on SMi’s download centre at www.pain-therapeutics.co.uk

Holiday Inn Kensington Forum , London UK

About SMi Group

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries.
We pride ourselves on having access to the worlds most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. We hold events in over 30 major cities throughout the world including London, Paris and Singapore and to date have welcomed over 200,000 participants from 80 countries.

More information can be found at www.smi-online.co.uk

Teri Arri
SMi Group Ltd
+44 (0)20 7827 6162
email us here

Powered by EIN Presswire